Risk Factor | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
HR | 95% CI | p Value | HR | 95% CI | p Value | |
Sex (F vs. M) | 1.452 | 0.804–2.621 | 0.216 | |||
Age (≤60 y vs. > 60 y) | 1.039 | 0.597–1.807 | 0.893 | |||
ECOG (0 + 1 vs. 2) | 0.840 | 0.335–2.110 | 0.711 | |||
Child (A vs. B) | 0.583 | 0.209–1.629 | 0.304 | |||
Treatment method (TACE-I-125 vs. TACE) | 0.448 | 0.265–0.758 | 0.003** | 0.482 | 0.276 ~ 0.841 | 0.010* |
Type of PVTT (VP1 + VP2 vs. VP3) | 0.421 | 0.247–0.719 | 0.002** | 0.399 | 0.229 ~ 0.696 | 0.001* |
Number of tumors (Single vs. Multiple) | 0.800 | 0.479–1.338 | 0.352 | |||
Tumor Size (≤5 vs. > 5) | 0.699 | 0.362–1.348 | 0.285 | |||
Extrahepatic metastasis (No vs Yes) | 0.933 | 0.423–2.063 | 0.863 | |||
AFP (≤400 ng/mL vs. > 400 ng/mL) | 0.606 | 0.344–1.066 | 0.082** | 0.706 | 0.388 ~ 1.285 | 0.254 |